Other research analysts have also issued research reports about the stock. ValuEngine upgraded shares of DowDuPont from a sell rating to a hold rating in a research note on Tuesday, August 28th. MED reiterated a buy rating and set a $90.00 price objective on shares of DowDuPont in a research note on Thursday, August 2nd. Barclays reduced their price objective on shares of DowDuPont from $77.00 to $75.00 and set an equal weight rating for the company in a research note on Monday, August 6th. UBS Group boosted their price objective on shares of DowDuPont from $86.00 to $88.00 and gave the stock a buy rating in a research note on Thursday, August 2nd. Finally, BNP Paribas assumed coverage on shares of DowDuPont in a research note on Tuesday, October 2nd. They set a neutral rating and a $75.00 price objective for the company. One research analyst has rated the stock with a sell rating, five have given a hold rating and thirteen have assigned a buy rating to the stock. The company has a consensus rating of Buy and an average price target of $80.31.
Shares of DWDP traded up $0.68 during mid-day trading on Friday, hitting $59.66. The company’s stock had a trading volume of 10,152,339 shares, compared to its average volume of 8,590,880. DowDuPont has a 52-week low of $58.81 and a 52-week high of $77.08. The stock has a market capitalization of $149.78 billion, a PE ratio of 17.55, a PEG ratio of 1.54 and a beta of 1.35. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.15 and a current ratio of 1.70.
The business also recently declared a quarterly dividend, which will be paid on Friday, December 14th. Shareholders of record on Friday, November 30th will be paid a dividend of $0.38 per share. The ex-dividend date of this dividend is Thursday, November 29th. This represents a $1.52 dividend on an annualized basis and a yield of 2.55%. DowDuPont’s payout ratio is 44.71%.
In other DowDuPont news, General Counsel Charles J. Kalil sold 100,645 shares of the company’s stock in a transaction that occurred on Monday, August 27th. The shares were sold at an average price of $70.75, for a total transaction of $7,120,633.75. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Edward D. Breen purchased 29,580 shares of the business’s stock in a transaction on Wednesday, August 8th. The shares were bought at an average price of $67.61 per share, for a total transaction of $1,999,903.80. The disclosure for this purchase can be found here. Corporate insiders own 0.42% of the company’s stock.
Large investors have recently added to or reduced their stakes in the company. Winthrop Partners WNY LLC purchased a new stake in DowDuPont during the first quarter worth $111,000. Cascade Investment Advisors Inc. lifted its holdings in DowDuPont by 85.1% during the second quarter. Cascade Investment Advisors Inc. now owns 1,794 shares of the company’s stock valued at $118,000 after purchasing an additional 825 shares in the last quarter. SG3 Management LLC purchased a new position in DowDuPont during the second quarter valued at $132,000. D. Scott Neal Inc. purchased a new position in DowDuPont during the second quarter valued at $152,000. Finally, Credit Agricole S A purchased a new position in DowDuPont during the second quarter valued at $160,000. Hedge funds and other institutional investors own 69.42% of the company’s stock.
DowDuPont Inc, through its subsidiaries, engages in agriculture, materials science, and specialty products businesses worldwide. The company's Agriculture segment develops and sells hybrid corn seed and soybean seed varieties; canola, cotton, sunflower, sorghum, wheat, and rice seeds; silage inoculants; and weed control, disease control, and insect control products.
Read More: Tariff
Receive News & Ratings for DowDuPont Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DowDuPont and related companies with MarketBeat.com's FREE daily email newsletter.